Neural stimulation for Parkinson’s disease: current therapies and future directions

References

• Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson’s disease. Mov. Disord. 18(1), 19–31 (2003).
   PubMed Web of Science ®Google Scholar
• Schoenberg BS. Descriptive epidemiology of Parkinson’s disease: disease distribution and hypothesis formulation. Adv. Neurol. 45, 277–283 (1987).
   PubMedGoogle Scholar
• Tanner CM, Goldman SM. Epidemiology of Parkinson’s disease. Neurol. Clin. 14(2), 317–335 (1996).
   PubMed Web of Science ®Google Scholar
• Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson’s disease. A community-based study. Brain 123(Pt 11), 2297–2305 (2000).
   PubMed Web of Science ®Google Scholar
• Poole JL. Psychosurgery in older people. J. Am. Geriatr. Soc. 2, 456–466 (1954).
   PubMedGoogle Scholar
• Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson’s disease. Appl. Neurophysiol.50(1–6), 344–346 (1987).
   PubMedGoogle Scholar
• Siegfried J. Effect of stimulation of the sensory nucleus of the thalamus on dyskinesia and spasticity. Rev. Neurol. 142(4), 380–333 (1986).
   PubMedGoogle Scholar
• Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery35(6), 1126–1129 (1994).
   PubMed Web of Science ®Google Scholar
• Stanzione P, Mazzone P, Peppe A, Pierantozzi M, Stefani A. Antiparkinsonian and antilevodopa-induced dyskinesia effects obtained by stimulating the same site within the GPi in PD. Neurology 51(6), 1776–1777 (1998).
   PubMedGoogle Scholar
• Kumar R, Lang AE, Rodriguez-Oroz MC, Lozano AM, Limousin P. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson’s disease. Neurology 55(12 Suppl. 6), S34–S39 (2000).
   PubMedGoogle Scholar
• Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942), 91–95 (1995).
   PubMed Web of Science ®Google Scholar
• Mazzone P, Lozano A, Stanzione P, Galati S, Scarnati E. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport16(17), 1877–1881 (2005).
   PubMed Web of Science ®Google Scholar
• Canavero S, Bonicalzi V. Cortical stimulation for parkinsonism. Arch. Neurol. 61(4), 606 (2004).
   PubMedGoogle Scholar
• Langston JW, Ballard PA. Parkinson’s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N. Engl. J. Med. 309(5), 310 (1983).
   PubMed Web of Science ®Google Scholar
• Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587), 979–980 (1983).
   PubMed Web of Science ®Google Scholar
• Kolata G. Monkey model of Parkinson’s disease. Science 220(4598), 705 (1983).
   PubMed Web of Science ®Google Scholar
• Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology35(7), 949–956 (1985).
   PubMed Web of Science ®Google Scholar
• Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12(10), 366–375 (1989).
   PubMed Web of Science ®Google Scholar
• Fénelon G, François C, Percheron G, Yelnik J. Topographic distribution of pallidal neurons projecting to the thalamus in macaques. Brain Res. 520(1–2), 27–35 (1990).
   PubMedGoogle Scholar
• Mengual E, de las Heras S, Erro E, Lanciego JL, Giménez-Amaya JM. Thalamic interaction between the input and the output systems of the basal ganglia. J. Chem. Neuroanat. 16(3), 187–200 (1999).
   PubMed Web of Science ®Google Scholar
• Hammond C, Rouzaire-Dubois B, Féger J, Jackson A, Crossman AR. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience 9(1), 41–52 (1983).
   PubMed Web of Science ®Google Scholar
• Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology. A critical review. Adv. Neurol.74, 3–18 (1997).
   PubMed Web of Science ®Google Scholar
• Obeso JA, Rodríguez-Oroz MC, Rodríguez M, Lanciego JL, Artieda J. Pathophysiology of the basal ganglia in Parkinson’s disease. Trends Neurosci. 23(Suppl. 10), S8–S19 (2000).
   PubMed Web of Science ®Google Scholar
• Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson’s disease. Brain123 (Pt 9), 1767–1783 (2000).
   PubMed Web of Science ®Google Scholar
• Mink JW, Thach WT. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. J. Neurophysiol. 65(2), 273–300 (1991).
   PubMed Web of Science ®Google Scholar
• Mink JW, Thach WT. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters J. Neurophysiol.65(2), 301–329 (1991).
   PubMedGoogle Scholar
• Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement J. Neurophysiol. 65(2), 330–351 (1991).
   PubMed Web of Science ®Google Scholar
• Benabid AL, Benazzous A, Pollak P. Mechanisms of deep brain stimulation. Mov. Disord. 17(Suppl. 3), S73–S74 (2002).
   PubMed Web of Science ®Google Scholar
• Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus J. Neurophysiol. 84(1), 570–574 (2000).
   PubMed Web of Science ®Google Scholar
• Filali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp. Brain Res. 156(3), 274–281 (2004).
   Google Scholar
• Welter ML, Houeto JL, Bonnet AM, Bejjani PB, Mesnage V. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch. Neurol. 61(1), 89–96 (2004).
   PubMedGoogle Scholar
• Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 55(12 Suppl. 6), S13–S16 (2000).
   PubMed Web of Science ®Google Scholar
• Anderson ME, Postupna N, Ruffo M. Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey. J. Neurophysiol. 89(2), 1150–1160 (2003).
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J. Neurosci. 23(5), 1916–1923 (2003).
   PubMed Web of Science ®Google Scholar
• Stefani A, Fedele E, Galati S, Pepicelli O, Frasca S. Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in Parkinson’s disease patients. Ann. Neurol. 57(3), 448–452 (2005).
   PubMed Web of Science ®Google Scholar
• McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol. 115(6), 1239–1248 (2004).
   PubMed Web of Science ®Google Scholar
• McIntyre CC, Grill WM, Sherman DL, Thakor NV. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J. Neurophysiol. 91(4), 1457–1469 (2004).
   PubMed Web of Science ®Google Scholar
• Langston JW, Widner H, Goetz CG, Brooks D, Fahn S. Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 7(1), 2–13 (1992).
   PubMed Web of Science ®Google Scholar
• Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD) Mov. Disord. 14(4), 572–584 (1999).
   PubMed Web of Science ®Google Scholar
• Pahwa R, Wilkinson SB, Overman J, Lyons KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with parkinson’s disease. Stereotact. Funct. Neurosurg. 83(2–3), 80–83 (2005).
   PubMed Web of Science ®Google Scholar
• Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in Parkinsonism. Eur. Neurol. 43(2), 95–101 (2000).
   PubMedGoogle Scholar
• Hughes AJ, Lees AJ, Stern GM. Challenge tests to predict the dopaminergic response in untreated Parkinson’s disease. Neurology 41(11), 1723–1725 (1991).
   PubMedGoogle Scholar
• Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol. Clin. 10(2), 405–20 (1992).
   PubMedGoogle Scholar
• Saint-Cyr JA, Hoque T, Pereira LC, Dostrovsky JO, Hutchison WD. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J. Neurosurg. 97(5), 1152–1166 (2002).
   PubMedGoogle Scholar
• Committee MotUD. Unified Parkinson’s disease rating scale. In: Recent Developments in Parkinson’s disease. Fahn S, Elton RL (Eds). Macmillan Healthcare, NJ, USA (1986).
   Google Scholar
• Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM,. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 337(8738), 403–406 (1991).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson’s disease Lancet. 350(9092), 1675 (1997).
   PubMed Web of Science ®Google Scholar
• Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson’s disease Lancet. 350(9092), 1676 (1997).
   PubMed Web of Science ®Google Scholar
• Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson’s disease: results of a randomized, blinded pilot study Neurosurgery. 45(6), 1375–1382 (1999).
   PubMed Web of Science ®Google Scholar
• Peppe A, Pierantozzi M, Bassi A, Altibrandi MG, Brusa L. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson’s disease. J. Neurosurg. 101(2), 195–200 (2004).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128(Pt 10), 2240–2249 (2005).
   PubMedGoogle Scholar
• Ondo WG, Bronte-Stewart H. The north american survey of placement and adjustment strategies for deep brain stimulation. Stereotact. Funct. Neurosurg. 83(4), 142–147 (2005).
   PubMed Web of Science ®Google Scholar
• Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: methodologic aspects and clinical criteria. Neurology 55(12 Suppl. 6), S40–S44 (2000).
   PubMed Web of Science ®Google Scholar
• Henderson JM. Frameless localization for functional neurosurgical procedures: a preliminary accuracy study. Stereotact. Funct. Neurosurg. 82(4), 135–141 (2004).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JM, Konrad PE, Nickele C, Cetinkaya E, Kao C. Accuracy of customized miniature stereotactic platforms. Stereotact. Funct. Neurosurg. 83(1), 25–31 (2005).
   PubMed Web of Science ®Google Scholar
• Eskandar E, Shinobu LA, Penney JBJ, Cosgrove GR. Non-microelectrode guided stereotactic pallidotomy for Parkinson’s disease: surgical technique and results. Stereotact. Funct. Neurosurg.72(2–4), 245 (1999).
   PubMedGoogle Scholar
• Hariz MI, Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotact. Funct. Neurosurg. 72(2–4), 157–169 (1999).
   PubMed Web of Science ®Google Scholar
• Andrade-Souza YM, Schwalb JM, Hamani C, Eltahawy H, Hoque T. Comparison of three methods of targeting the subthalamic nucleus for chronic stimulation in Parkinson’s disease. Neurosurgery. 56(Suppl. 2), 360–368 (2005).
   PubMedGoogle Scholar
• Nowinski WL, Belov D, Pollak P, Benabid AL. A probabilistic functional atlas of the human subthalamic nucleus. Neuroinformatics 2(4), 381–398 (2004).
   PubMedGoogle Scholar
• Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery. 56(6), 1313–1321 (2005).
   PubMed Web of Science ®Google Scholar
• Berney A, Vingerhoets F, Perrin A, Guex P, Villemure JG,. Effect on mood of subthalamic deep brain stimulation for Parkinson’s disease: a consecutive series of 24 patients Neurology 59(9), 1427–1429 (2002).
   PubMed Web of Science ®Google Scholar
• Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson’s disease. J. Clin. Psych. 65(6), 845–859 (2004).
   Google Scholar
• Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease Mov. Disord. 18(5), 524–530 (2003).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Jimbo M, Ide M, Tanaka N, Umebara Y, Hagiwara S. Postoperative neurosurgical infection and antibiotic prophylaxis. Neurol. Med. Chir (Tokyo). 32(2), 72–79 (1992).
   Google Scholar
• Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism. Eur. Neurol.44(3), 147–152 (2000).
   PubMed Web of Science ®Google Scholar
• Dromey C, Kumar R, Lang AE, Lozano AM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov. Disord. 15(6), 1132–1138 (2000).
   PubMed Web of Science ®Google Scholar
• Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 123 (Pt 10), 2091–108 (2000).
   PubMedGoogle Scholar
• Santens P, De Letter M, Van Borsel J, De Reuck J, Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson’s disease. Brain Lang. 87(2), 253–258 (2003).
   PubMed Web of Science ®Google Scholar
• Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 63(11), 2170–2172 (2004).
   PubMed Web of Science ®Google Scholar
• Nandi D, Liu X, Winter JL, Aziz TZ, Stein JF. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. J. Clin. Neurosci. 9(2), 170–174 (2002).
   PubMed Web of Science ®Google Scholar
• Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport15(17), 2621–2624 (2004).
   PubMed Web of Science ®Google Scholar
• Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport 16(17), 1883–1887 (2005).
   PubMed Web of Science ®Google Scholar
• Katayama Y, Fukaya C, Yamamoto T. Control of poststroke involuntary and voluntary movement disorders with deep brain or epidural cortical stimulation. Stereotact. Funct. Neurosurg. 69(1–4 Pt 2), 73–79 (1997).
   PubMed Web of Science ®Google Scholar
• Garcia-Larrea L, Peyron R, Mertens P, Gregoire MC, Lavenne F. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 83(2), 259–273 (1999).
   PubMed Web of Science ®Google Scholar
• Canavero S, Paolotti R, Bonicalzi V, Castellano G, Greco-Crasto S,. Extradural motor cortex stimulation for advanced Parkinson’s disease. Report of two cases. J. Neurosurg. 97(5), 1208–1211 (2002).
   PubMed Web of Science ®Google Scholar
• Canavero S, Paolotti R. Extradural motor cortex stimulation for advanced Parkinson’s disease: case report. Mov. Disord. 15(1), 169–171 (2000).
   PubMed Web of Science ®Google Scholar
• Nakao N, Nakai E, Nakai K, Itakura T. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann. Neurol. 45(5), 640–651 (1999).
   PubMedGoogle Scholar
• Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L. Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psych. 76(9), 1217–1221 (2005).
   PubMedGoogle Scholar